Gynecology and Obstetrics

About Conference

The 12th International Conference on Gynecology and Obstetrics will be held on June 25-26, 2026 Paris, France This distinguished global event is designed to bring together leading experts, researchers, and practitioners to explore the latest innovations and breakthroughs in women’s health. Covering a broad spectrum of topics—from reproductive health and fetal medicine to advanced management of complex gynecological conditions—the conference provides an exceptional platform for scientific exchange and collaboration.

In addition to keynote lectures and panel discussions, participants will have access to interactive workshops, hands-on sessions, and valuable networking opportunities. Set against the backdrop of Paris—renowned for its medical heritage and academic excellence—the event promises an inspiring environment for learning, idea-sharing, and professional growth. With contributions from world-class clinicians and researchers, the conference is poised to be a landmark gathering in the field of gynecology and obstetrics.

Why Attend?

Attending the 12th International Conference on Gynecology and Obstetrics offers a unique opportunity to stay at the cutting edge of advancements in women’s healthcare. You will:

• Engage with globally recognized experts and thought leaders.

• Gain insights into the latest research, emerging technologies, and evidence-based treatments.

• Participate in specialized workshops and focused scientific sessions.

• Network with peers, collaborators, and industry professionals.

• Explore new avenues for research, partnerships, and clinical improvement.

Target Audience

• Obstetricians

• Gynecologists

• Women’s Health Professionals

• Medical and Clinical Researchers

• Scientists in Reproductive & Maternal Health

• Medical Students, Residents, and Fellows

• Nurses, Midwives, and Allied Health Professionals

• Healthcare Administrators and Hospital Leaders

• Pharmaceutical and Biotechnology Representatives

• Medical Device and Technology Developers

• Public Health Specialists

• Policy Makers and Regulators in Women’s Health

• Medical Educators, Trainers, and Academic Faculty

• Health Media, Medical Journalists, and Science Communicators

• Women’s Health Advocacy Groups and NGOs

• Patients, Caregivers, and Patient Advocacy Organizations

Sessions and Tracks

Track-1: Maternal–Fetal Medicine & High-Risk Pregnancy

Advancements in maternal–fetal medicine are transforming how clinicians identify, predict, and manage high-risk pregnancies. This track explores breakthrough diagnostic tools, predictive fetal imaging, and precision-based maternal care. Discussions will include gestational hypertension, preterm birth prevention, and new fetal monitoring technologies. Experts will also highlight global disparities in high-risk pregnancy outcomes. A focus will be placed on integrating AI-driven risk stratification models. The goal is to enhance maternal safety and improve fetal survival worldwide.

Track-2: Gynecologic Oncology & Innovative Cancer Therapies

This track examines cutting-edge progress in the diagnosis and treatment of gynecologic cancers. Topics include immunotherapy, targeted molecular agents, and evolving surgical approaches in ovarian, cervical, and endometrial cancers. The role of genetic counseling and BRCA-based therapies will be highlighted. Researchers will also discuss early detection technologies. Emphasis will be placed on survivorship, quality of life, and minimally invasive oncology care.

Track-3: Reproductive Endocrinology & Infertility Management

Rapid advancements in reproductive endocrinology are improving fertility outcomes for couples worldwide. This track covers modern IVF technologies, ovarian stimulation protocols, and fertility preservation for cancer patients. Experts will discuss endocrine disorders such as PCOS, hypothalamic dysfunction, and luteal phase insufficiency. Emerging trends like in-vitro gametogenesis and gene editing will be reviewed. A special focus will address ethical considerations in assisted reproduction.

Track-4: Advances in Minimally Invasive Gynecologic Surgery

This track highlights innovation in laparoscopic, hysteroscopic, and robotic gynecologic surgery. Presenters will review improved visualization systems, surgical precision tools, and real-time digital navigation. Sessions will explore ERAS protocols that enhance postoperative recovery. Training models and simulation technologies will be featured. Discussions will examine the safety, cost-effectiveness, and future expansion of minimally invasive procedures.

Track-5: Urogynecology & Pelvic Floor Dysfunctions

Pelvic floor disorders significantly affect women’s quality of life across all ages. This track focuses on urinary incontinence, pelvic organ prolapse, and pelvic reconstructive surgery. Researchers will share new insights in pelvic muscle physiology and biofeedback therapies. Advanced mesh-free surgical approaches will be discussed. The track also highlights postpartum pelvic injury diagnostics and rehabilitation. Preventive strategies and patient-centered approaches will be emphasized.

Track-6: Neonatal Care & Perinatal Health Innovations

This track examines neonatal intensive care advancements and perinatal health strategies. Emphasis will be placed on early detection of fetal compromise and preterm birth risk. Sessions will review neonatal resuscitation updates, growth monitoring, and metabolic screening. New technologies such as AI-assisted NICU monitoring will be included. Improving newborn survival in low-resource settings will be a core theme.

Track-7: Obstetric Emergencies & Critical Care

Managing obstetric emergencies requires rapid decision-making and skilled critical care. This track explores updated protocols for postpartum hemorrhage, eclampsia, sepsis, and amniotic fluid embolism. Presenters will address trauma in pregnancy and critical life-support interventions. Simulated emergency training and team-based approaches will be highlighted. Emphasis will be placed on outcome improvement through early warning systems.

Track-8: Sexual & Reproductive Health Rights

This track focuses on the global landscape of women’s reproductive rights and access to evidence-based care. Discussions will include contraception availability, safe abortion practices, and reproductive justice. Experts will explore policy reforms, cultural barriers, and socioeconomic determinants. A focus will be placed on adolescent reproductive health education. Strategies for improving access in underserved communities will be prioritized.

Track-9: Contraception & Family Planning Advances

Family planning continues to evolve with new long-acting reversible contraceptives and personalized counseling approaches. This track reviews hormonal, non-hormonal, and permanent contraception options. Emphasis will be placed on emerging male contraceptives. Presenters will highlight shared decision-making models that enhance user satisfaction. Access and affordability challenges in global regions will also be discussed.

Track-10: Prenatal Genetics & Genomic Medicine

Genomic medicine is transforming prenatal screening and diagnosis. This track explores NIPT innovations, carrier screening expansion, and genetic counseling challenges. Presentations will examine the clinical use of whole-genome sequencing. Ethical issues surrounding fetal genetic data will be discussed. The integration of precision medicine into obstetric practice will be a core theme.

Track-11: Menopause & Midlife Women’s Health

As life expectancy increases, midlife women’s health has become a global priority. This track covers hormone therapy advancements, menopausal symptom management, and bone health. Sessions will explore metabolic risks and cardiovascular changes during menopause. Non-hormonal therapies and lifestyle approaches will be reviewed. A patient-centered model for menopausal care will be emphasized.

Track-12: Adolescent Gynecology & Young Women’s Health

This track focuses on the unique gynecological needs of adolescents. Topics include menstrual disorders, pubertal abnormalities, and adolescent PCOS. The psychological impacts of early reproductive health challenges will be discussed. Presenters will also address HPV vaccination, sexual education, and consent. Improving adolescent-friendly healthcare environments will be highlighted.

Track-13: Endometriosis & Chronic Pelvic Pain Updates

Endometriosis remains a major cause of infertility and chronic pain. This track explores updated diagnostic tools, biomarkers, and imaging modalities. Presenters will review medical therapies and advanced excision techniques. Sessions will highlight patient experiences and quality-of-life outcomes. Multidisciplinary treatment models will be emphasized to improve long-term disease management.

Track-14: Maternal Mental Health & Postpartum Wellbeing

This track investigates the psychological dimensions of pregnancy and motherhood. Key areas include postpartum depression, anxiety disorders, and perinatal stress. Presenters will highlight screening tools and early intervention strategies. The link between maternal mental health and infant development will be explored. Culturally sensitive counseling and digital support systems will be reviewed.

Track-15: Innovations in Obstetric Imaging & Diagnostics

Advanced imaging is reshaping prenatal and gynecological assessments. This track reviews breakthroughs in 3D/4D ultrasound, MRI applications, and Doppler technologies. Case studies will illustrate complex fetal evaluations. Presenters will discuss AI-enhanced image interpretation. Training challenges and future imaging possibilities will also be covered.

Track-16: Global Maternal Mortality Reduction Strategies

Despite progress, maternal mortality remains a critical global issue. This track examines evidence-based interventions to reduce complications. Speakers will highlight scalable strategies for low-resource regions. Improving midwifery training, emergency transport, and community awareness will be emphasized. Policy reforms and sustainable health systems will also be discussed.

Track-17: Immunology in Pregnancy & Reproductive Health

Understanding maternal immune adaptation is essential for healthy pregnancies. This track explores immunologic mechanisms in implantation, placental function, and fetal tolerance. Researchers will discuss autoimmune conditions and their reproductive impact. Novel immunotherapies and biologics will be highlighted. The role of infections in pregnancy outcomes will also be examined.

Track-18: Maternal Nutrition & Lifestyle Medicine

Nutrition profoundly influences maternal, fetal, and long-term child health. This track discusses gestational weight management, micronutrient needs, and metabolic risks. Presentations will explore the impact of lifestyle medicine, physical activity, and sleep. Evidence-based dietary interventions will be shared. Strategies for minimizing obesity-related pregnancy complications will be highlighted.

Track-19: Gynecologic Infectious Diseases

This track focuses on sexually transmitted infections, pelvic inflammatory disease, and emerging pathogens. Presenters will highlight updated diagnostic criteria and targeted therapies. Sessions will explore HPV, HSV, syphilis resurgence, and antimicrobial resistance. Preventive approaches and vaccination strategies will be emphasized. The impact of infections on fertility and pregnancy outcomes will also be covered.

Track-20: Maternal–Fetal Pharmacology & Drug Safety

Medication use during pregnancy requires careful consideration for fetal safety. This track discusses pharmacokinetics, teratogenic risks, and evidence-based prescribing. Experts will examine treatment strategies for chronic diseases during pregnancy. Cases involving psychotropic drugs, antibiotics, and herbal supplements will be reviewed. Development of safe drug alternatives will also be featured.

Track-21: Ethics, Law & Controversies in Women’s Health

This track addresses ethical dilemmas and legal considerations in obstetrics and gynecology. Topics include surrogacy, consent, fetal rights, and telemedicine regulations. Presenters will discuss emerging controversies in reproductive genetics. The importance of transparent communication and ethical decision-making will be emphasized. Case-based discussions will provide practical insights.

Track-22: Digital Health, AI & Smart Technologies in OBGYN

AI and digital platforms are reshaping women’s healthcare delivery. This track explores tele-obstetrics, wearable monitoring systems, and predictive analytics. Digital tools for labor management and surgical planning will be highlighted. Sessions will review cybersecurity concerns and data governance. The future of virtual maternal-fetal care will be a key focus.

Track-23: Obstetric Anesthesia & Pain Management

Safe anesthesia practices are crucial for maternal wellbeing. This track reviews updated labor analgesia protocols, regional anesthesia techniques, and postoperative pain strategies. Presenters will address anesthesia in high-risk pregnancies and complex comorbidities. Innovations in non-pharmacologic pain management will also be explored. Simulation-based training will be discussed.

Track-24: Breast Health, Lactation & Postnatal Care

This track covers breast disorders, lactation challenges, and postpartum recovery. Sessions will highlight mastitis management, breastfeeding promotion, and hormonal influences. Presenters will discuss screening strategies for postpartum breast complications. Supportive care models for new mothers will be emphasized. Innovations in lactation support technologies will also be examined.

Track-25: Regenerative Medicine & Reproductive Tissue Engineering

Breakthroughs in tissue engineering are opening new possibilities in reproductive medicine. This track discusses stem-cell therapies, artificial ovaries, and uterine regeneration research. Presenters will explore biomaterials used in gynecologic reconstruction. Ethical and safety considerations will be highlighted. The future potential of regenerative gynecology will be a major focus.

Track-26: Public Health, Policy & Community Obstetric Care

Improving women’s health requires coordinated public health initiatives. This track reviews national programs, maternal audits, and community-based interventions. Experts will analyze health equity gaps and propose sustainable solutions. The role of public–private partnerships will be emphasized. Strategies for culturally competent obstetric care will also be reviewed.

Market Analysis

As the global economy recovers, the Obstetrics and Gynecology Cots market is expected to undergo significant changes compared to the previous year. According to our latest analysis, the global market size for Obstetrics and Gynecology Cots reached USD million in 2022, up from USD million in 2021, reflecting a growth of % between 2021 and 2022. The market is projected to reach USD million by 2028, expanding at a CAGR of % during the forecast period.

In the United States, the Obstetrics and Gynecology Cots market was valued at USD million in 2021 and is anticipated to grow at approximately % CAGR throughout the review period. China accounts for % of the global market and is expected to reach USD million by 2028. Within Europe, Germany is projected to achieve a market value of USD million by 2028, growing at a CAGR of % over the forecast timeline. In the Asia-Pacific region, Japan and South Korea are estimated to exhibit CAGRs of % and %, respectively, over the next five years.

Major global players in the Obstetrics and Gynecology Cots market include Ferno, Stryker, Hill-Rom, GIVAS, among others. The top two companies collectively held nearly % of the market share in 2021.

This report provides a comprehensive overview of the market, including market share analysis, key segments, growth opportunities, and competitive landscape based on product type, application, leading manufacturers, and major regions and countries.

Overall, the global Obstetrics and Gynecology Cots market is projected to grow at a notable pace from 2022 to 2028. While the market showed steady growth in 2021, increasing adoption of advanced solutions by key players is expected to accelerate expansion throughout the forecast period.